Type 2 diabetes is a long-term condition in which the body does not use insulin well or does not make enough of it, so sugar builds up in the blood instead of being used for energy. Over time, high blood sugar can affect different parts of the body, including the heart, kidneys, eyes, nerves and feet, which is why ongoing management matters.
Because treatment goals vary from person to person, they are determined by a healthcare professional. It’s also why treatment options have continued to evolve to suit patient requirements and their ease of administration. One option that you may have heard about is semaglutide.
What is semaglutide?
Semaglutide belongs to a class of medicines called GLP-1 receptor agonists. GLP-1, or Glucagon-Like Peptide-1, is a natural hormone released by the gut after meals that plays a role in blood sugar regulation.
A receptor can be thought of as a docking site on a cell, while an agonist is a compound that activates that site. Semaglutide works by interacting with GLP-1 receptors and mimicking the action of the body's natural GLP-1 hormone. It shares approximately 94% structural similarity with human GLP-1, allowing it to activate the same biological pathways.
A short history of semaglutide
Researchers became interested in GLP-1 because of its role in the body's natural glucose-regulation processes. Since the body's natural GLP-1 is broken down within a few minutes, any therapy would require continuous injections. The design of Semaglutide allows it to bind to albumin, a naturally occurring protein in the blood, which helps the medicine stay in the body longer and resist breakdown. This extended action enables semaglutide to provide sustained effects on blood sugar control with one dose per week as prescribed by the healthcare professional.
As with all prescription medicines, whether semaglutide is appropriate for an individual depends on their medical history, treatment goals and overall health. This is a discussion best had with a healthcare professional.
Talking to your doctor about treatment
Whether a treatment plan based on semaglutide injections may be suitable for you is something your doctor can help determine. Treatment decisions are based on a range of factors, including your medical history, current health status, other medicines you may be taking, and your overall diabetes management plan.
If you would like to know more about semaglutide, you may wish to ask your doctor:
Treatment goes beyond medication
Medication is only one part of managing Type 2 diabetes. Day-to-day habits also play an important role, and your healthcare team can help you build a routine that suits your needs, including:
Making the most of your appointments
To help your healthcare professional make informed treatment decisions, it can be useful to share details about any existing medical conditions, medicines, supplements or herbal products you use, as well as any past reactions to medicines. You should also let your doctor know if you are pregnant, planning a pregnancy, breastfeeding, or have a history of digestive or pancreas-related conditions. Keeping a record of blood sugar readings (if advised), symptoms and questions between appointments can help make discussions more productive and ensure important concerns are not overlooked.
Semaglutide is one of several treatment options that may be considered as part of Type 2 diabetes management. Whether you are researching a semaglutide injection for the first time or looking to understand your treatment options better, learning about the condition and having open conversations with your healthcare professional can help you make informed decisions about your care. Because every person's health needs are different, the most appropriate treatment approach should always be determined in consultation with a qualified healthcare professional.
References:
1 Tamayo-Trujillo R, Ruiz-Pozo VA, Cadena-Ullauri S, Guevara-Ramírez P, Paz-Cruz E, Zambrano-Villacres R, Simancas-Racines D, Zambrano AK. Molecular mechanisms of semaglutide and liraglutide as a therapeutic option for obesity. Front Nutr. 2024 Apr 29;11:1398059. doi: 10.3389/fnut.2024.1398059. PMID: 38742021; PMCID: PMC11090168.
2 Røder ME. Clinical potential of treatment with semaglutide in type 2 diabetes patients. Drugs Context. 2019 Dec 2;8:212585. doi: 10.7573/dic.212585. PMID: 31844422; PMCID: PMC6905643.
3 Knudsen LB, Lau J. The Discovery and Development of Liraglutide and Semaglutide. Front Endocrinol (Lausanne). 2019 Apr 12;10:155. doi: 10.3389/fendo.2019.00155. PMID: 31031702; PMCID: PMC6474072.
4 Shalvi Sunil Pawar, Pooja Balkrishna Rasal , Kiran Hemant Kulkarni , Suyash Balasaheb Pawar. Semaglutide: A Comprehensive Review of its Pharmacology, Clinical Applications, and Future Therapeutic Potential. Department of Pharmacology, SND College Of Pharmacy.
Disclaimer: Issued in public interest by Abbott for general awareness only. Content is based on scientific references. Nothing contained in this article constitutes or implies medical advice, endorsement, sponsorship, purchase or recommendation of any kind. Please consult your doctor for more information or medical advice.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.
